EUVIMEDEUVIMED entdecken
Crossref

Clinical Outcomes in Living Donor Kidney Transplantation: A Single Center Experience in Latin America

Yenny Baez-Suarez, Andrea Garcia-Lopez, Nasly Patino-Jaramillo, Fernando Giron-Luque

Transplantation Proceedings · 2023

DOI: 10.1016/j.transproceed.2022.11.014 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Transplantation Proceedings, 2023. Verfasst von Yenny Baez-Suarez und 3 weiteren Autor:innen. Beteiligte Einrichtung: Department of Transplant Surgery, Colombiana de Trasplantes, Bogotá, Colombia. Hauptthemen laut MEDLINE: Kidney Transplantation. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 39 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

BACKGROUND: In Latin America, few reports are available about the clinical outcomes of living donor kidney transplants (LDKT). We aim to evaluate the main clinical outcomes for LDKT patients in a single center's experience. METHODS: We retrospectively evaluated 530 LDKT patients who underwent transplantation from August 2008 to December 2020 at Colombiana de Trasplantes. Graft survival censored for death and patient survival were determined up to 5 years post-transplantation by the Kaplan-Meier method. Vascular and urinary complications, readmission, and reintervention rates were documented. RESULTS: A total of 530 LDKT patients were analyzed. Most of the recipients were men (56%). There were 123 patients (23.2%) with a preemptive transplant. Panel reactive antibody type I and II had higher immunologic risk (>20%) in 15.9% of the patients. The donor mean age was 37.8 ± 11.5 years. Most of the donors were women (52.6%) and related to the recipient (69.1%). Multivariate analysis identified panel reactive antibody type II (P = 0.003), female donor (P = 0.001), surgical reintervention at 30 days post-transplantation (P < .01), and delayed graft function (P < .01) as risk factors for graft loss. The graft survival death-censored rates were 93.7% and 89% at 1 and 5 years, respectively. Patient survival rates were 97.0% and 94.1% at 1 and 5 years after transplantation, respectively. CONCLUSIONS: The long-term graft and patient survival rates in our center are comparable to previous reports from other leading centers. The clinical outcomes from a medium-sized center can be noteworthy, although not entirely new.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Kidney TransplantationMaleHumansFemaleAdultMiddle AgedLiving DonorsRetrospective StudiesLatin AmericaTreatment OutcomeGraft RejectionGraft SurvivalKidney

Autor:innen und Institutionen

  • Department of Transplant Surgery, Colombiana de Trasplantes, Bogotá, Colombia.
  • Department of Transplant Research, Colombiana de Trasplantes, Bogotá, Colombia. Electronic address: aegarcia@colombianadetrasplantes.com.
  • Department of Transplant Research, Colombiana de Trasplantes, Bogotá, Colombia.

Zitieren

APA

Baez-Suarez, Y., Garcia-Lopez, A., Patino-Jaramillo, N., & Giron-Luque, F. (2023). Clinical Outcomes in Living Donor Kidney Transplantation: A Single Center Experience in Latin America. Transplantation Proceedings. https://doi.org/10.1016/j.transproceed.2022.11.014

Vancouver

Baez-Suarez Y, Garcia-Lopez A, Patino-Jaramillo N, Giron-Luque F. Clinical Outcomes in Living Donor Kidney Transplantation: A Single Center Experience in Latin America. Transplantation Proceedings. 2023. doi:10.1016/j.transproceed.2022.11.014

BibTeX
@article{BaezSuarez2023,
  author = {Baez-Suarez, Yenny and Garcia-Lopez, Andrea and Patino-Jaramillo, Nasly and Giron-Luque, Fernando},
  title = {Clinical Outcomes in Living Donor Kidney Transplantation: A Single Center Experience in Latin America},
  journal = {Transplantation Proceedings},
  year = {2023},
  doi = {10.1016/j.transproceed.2022.11.014}
}
Kostenlos starten →